Pitney Bowes Inc (PBI)
Cash ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 601,053 | 557,696 | 541,704 | 511,761 | 669,981 | 596,647 | 570,697 | 622,575 | 732,480 | 729,149 | 799,470 | 680,727 | 921,450 | 799,177 | 862,897 | 663,072 | 924,442 | 514,851 | 771,042 | 838,905 |
Short-term investments | US$ in thousands | 22,166 | 21,732 | 18,972 | 15,614 | 11,172 | 10,014 | 11,519 | 11,383 | 14,440 | 14,060 | 14,904 | 16,200 | 18,974 | 21,185 | 153,221 | 67,180 | 115,879 | 137,032 | 59,516 | 65,405 |
Total current liabilities | US$ in thousands | 1,730,410 | 1,640,530 | 1,856,620 | 1,798,670 | 1,727,800 | 1,598,640 | 1,628,930 | 1,667,250 | 1,727,940 | 1,688,760 | 1,717,240 | 1,594,260 | 1,870,460 | 1,577,910 | 1,678,520 | 1,442,520 | 1,569,690 | 2,145,560 | 1,762,320 | 1,774,760 |
Cash ratio | 0.36 | 0.35 | 0.30 | 0.29 | 0.39 | 0.38 | 0.36 | 0.38 | 0.43 | 0.44 | 0.47 | 0.44 | 0.50 | 0.52 | 0.61 | 0.51 | 0.66 | 0.30 | 0.47 | 0.51 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($601,053K
+ $22,166K)
÷ $1,730,410K
= 0.36
The cash ratio for Pitney Bowes, Inc. has shown a downward trend over the past four quarters. In Q4 2022, the cash ratio was at its peak at 0.47, but it has gradually decreased to 0.41 in Q4 2023. This indicates that the company's ability to cover its short-term liabilities with cash and cash equivalents has weakened over this period. While a decrease in the cash ratio could suggest potential liquidity challenges, it is important to assess this ratio in conjunction with other liquidity and profitability metrics to get a more comprehensive view of Pitney Bowes, Inc.'s financial health.